Minitran (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Minitran, is an organic nitrate presented as a transdermal patch for transdermal use. It treats chronic stable angina pectoris and helps prevent angina attacks in adult patients.

GNH USA supplies Minitran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minitran (glyceryl trinitrate) is used in the management of coronary artery disease and related angina syndromes.

- Chronic stable angina pectoris: reduces frequency of angina episodes and improves exercise tolerance. - Prevention of angina attacks: provides continuous nitrate delivery to lessen sudden chest pain. - Adjunct therapy in acute coronary syndrome: used alongside standard care to improve myocardial oxygen balance.

Minitran may cause a range of adverse reactions, most of which are related to its vasodilatory properties.

Common Side Effects: - Headache: throbbing pain often occurring shortly after patch application. - Dizziness or light‑headedness: due to transient blood pressure reduction. - Flushing: warm sensation and reddening of the skin. - Skin irritation at the patch site: redness, itching, or mild rash. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause syncope. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare but reported in patients with unstable coronary disease. - Severe allergic reaction: anaphylaxis or angioedema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions. - Skin necrosis at the application site: uncommon but serious tissue damage.

Before prescribing Minitran, clinicians should consider several safety measures.

- Assess cardiovascular status: evaluate blood pressure and heart rate prior to initiation. - Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Monitor for tolerance development: efficacy may diminish with continuous use. - Educate patient on patch rotation: change site every 24 hours to reduce skin irritation. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Minitran can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Sildenafil and other PDE‑5 inhibitors: can cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drop. - Alcohol: potentiates hypotensive effect.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, beta‑blockers): may enhance blood pressure lowering. - Diuretics: increase risk of orthostatic hypotension. - Azole antifungals (e.g., ketoconazole): can raise nitrate plasma levels.